Beijing Chia Tai Green Continent Pharmaceutical

Beijing Chia Tai Green Continent Pharmaceutical is a specialized pharmaceutical company based in China, operating as a subsidiary of the CP Pharmaceutical Group (Sino Biopharmaceutical). The company focuses on the research, development, and commercialization of treatments for metabolic diseases, particularly type 2 diabetes and cardiovascular conditions. It is well-known for its portfolio of oral hypoglycemic agents and has established a significant presence in the Chinese domestic market through its integrated manufacturing and distribution capabilities. The firm leverages the extensive R&D resources of its parent conglomerate to advance its pipeline of both generic and innovative therapies.